A Comparative Analysis of Current Lipid Treatment Guidelines: Nothing Stands Still

Heart, Artery and Coronary Diseases

Diagnostic Performance of Hybrid Cardiac Imaging Methods for Assessment of Obstructive Coronary Artery Disease Compared With Stand-Alone Coronary Computed Tomography Angiography: A Meta-Analysis

JACC Cardiovasc Imaging.

Rizvi A, Han D, Danad I, Ó Hartaigh B, Lee JH, Gransar H, Stuijfzand WJ, Roudsari HM, Park MW, Szymonifka J, Chang HJ, Jones EC, Knaapen P, Lin FY, Min JK, Peña JM

doi: 10.1016/j.jcmg.2017.05.020.

RECOMMENDED

HypertensionLipid-Lowering DrugsThrombosis and Stroke

Long-term mortality after blood pressure-lowering and lipid-lowering treatment in patients with hypertension in the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) Legacy study: 16-year follow-up results of a randomised factorial trial

Lancet.

Gupta A, Mackay J, Whitehouse A, Godec T, Collier T, Pocock S, Poulter N, Sever P

doi: 10.1016/S0140-

RECOMMENDED

Heart, Artery and Coronary DiseasesLipid-Lowering Drugs

Effect of Simvastatin-Ezetimibe Compared With Simvastatin Monotherapy After Acute Coronary Syndrome Among Patients 75 Years or Older: A Secondary Analysis of a Randomized Clinical Trial

JAMA Cardiol.

Bach RG, Cannon CP, Giugliano RP, White JA, Lokhnygina Y, Bohula EA, Califf RM, Braunwald E, Blazing MA

doi: 10.1001/jamacardio.2019.2306.

Thrombosis and Stroke

Treatment and Outcomes of Patients With Ischemic Stroke During COVID-19: An Analysis From Get With The Guidelines-Stroke

Stroke

Srivastava PK, Zhang S, Xian Y, Xu H, Rutan C, Alger HM, Walchok JG, Williams JH, de Lemos JA, Decker-Palmer MR, Alhanti B, Elkind MSV, Messé SR, Smith EE, Schwamm LH, Fonarow GC

doi: 10.1161/STROKEAHA.120.034414

Cardiovascular Risk and DiseasesHypertensionLipid-Lowering Drugs

Effects of walnut consumption on blood lipids and other cardiovascular risk factors: an updated meta-analysis and systematic review of controlled trials

Am J Clin Nutr.

Guasch-Ferré M, Li J, Hu FB, Salas-Salvadó J, Tobias DK

doi: 10.1093/ajcn/nqy091.

Cardiovascular Risk and DiseasesLipid-Lowering DrugsMyocardial Infarction

Predicted impact of lipid lowering therapy on cardiovascular and economic outcomes of Swedish atherosclerotic cardiovascular disease guideline

BMC Cardiovasc Disord.

Journath G, Hambraeus K, Hagström E, Pettersson B, Löthgren M

doi: 10.1186/s12872-017-0659-2.

Cardiovascular Risk and DiseasesHypertension

Estimating the Association of the 2017 and 2014 Hypertension Guidelines With Cardiovascular Events and Deaths in US Adults: An Analysis of National Data

JAMA Cardiol.

Bundy JD, Mills KT, Chen J, Li C, Greenland P, He J

doi: 10.1001/

Therapy and Intervention

Systematic Evaluation of the Robustness of the Evidence Supporting Current Guidelines on Myocardial Revascularization Using the Fragility Index

Circ Cardiovasc Qual Outcomes.

Gaudino M, Hameed I, Biondi-Zoccai G, Tam DY, Gerry S, Rahouma M, Khan FM, Angiolillo DJ, Benedetto U, Taggart DP, Girardi LN, Crea F, Ruel M, Fremes SE

doi: 10.1161/CIRCOUTCOMES.119.006017.

Heart FailureHypertension

Reduced Risk of Hyperkalemia During Treatment of Heart Failure With Mineralocorticoid Receptor Antagonists by Use of Sacubitril/Valsartan Compared With Enalapril: A Secondary Analysis of the PARADIGM-HF Trial.

JAMA Cardiol.

Desai AS, Vardeny O, Claggett B, McMurray JJ, Packer M, Swedberg K, Rouleau JL, Zile MR, Lefkowitz M, Shi V, Solomon SD

doi: 10.1001/jamacardio.

Related content

Diagnostic Performance of Hybrid Cardiac Imaging Methods for Assessment of Obstructive Coronary Artery Disease Compared With Stand-Alone Coronary Computed Tomography Angiography: A Meta-Analysis

Long-term mortality after blood pressure-lowering and lipid-lowering treatment in patients with hypertension in the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) Legacy study: 16-year follow-up results of a randomised factorial trial

Effect of Simvastatin-Ezetimibe Compared With Simvastatin Monotherapy After Acute Coronary Syndrome Among Patients 75 Years or Older: A Secondary Analysis of a Randomized Clinical Trial

Treatment and Outcomes of Patients With Ischemic Stroke During COVID-19: An Analysis From Get With The Guidelines-Stroke

Effects of walnut consumption on blood lipids and other cardiovascular risk factors: an updated meta-analysis and systematic review of controlled trials

Predicted impact of lipid lowering therapy on cardiovascular and economic outcomes of Swedish atherosclerotic cardiovascular disease guideline

Estimating the Association of the 2017 and 2014 Hypertension Guidelines With Cardiovascular Events and Deaths in US Adults: An Analysis of National Data

Systematic Evaluation of the Robustness of the Evidence Supporting Current Guidelines on Myocardial Revascularization Using the Fragility Index

Reduced Risk of Hyperkalemia During Treatment of Heart Failure With Mineralocorticoid Receptor Antagonists by Use of Sacubitril/Valsartan Compared With Enalapril: A Secondary Analysis of the PARADIGM-HF Trial.